The Science
Perimenopause is not a single event but a convergence of shifting signals: declining estradiol disrupts hypothalamic-pituitary feedback, progesterone withdrawal destabilizes sleep and mood regulation, and the resulting hormonal volatility accelerates insulin resistance, bone resorption, and cardiovascular risk. These pathways interact and compound one another, linking reproductive aging directly to systemic healthspan decline.
How perimenopause impacts healthspan
Interventions that can help
Stabilize metabolic function
Estrogen loss impairs insulin sensitivity and shifts energy metabolism toward fat storage and inflammation. Targeting these metabolic pathways reduces cardiovascular risk accumulation and preserves mitochondrial efficiency during and after the transition.
Restore hormonal signaling
Bioidentical estrogen and progesterone replacement directly addresses the hormonal withdrawal driving vasomotor, cognitive, and metabolic symptoms, restoring the signaling environment that supports tissue protection across multiple organ systems.
Monitor hormonal biomarkers
Estradiol, progesterone, testosterone, FSH, and AMH levels shift dynamically throughout perimenopause. Precise, repeated measurement allows clinical protocols to track the transition in real time and adjust interventions as the hormonal landscape evolves.
Restore hormonal signaling
Bioidentical estrogen and progesterone replacement directly addresses the hormonal withdrawal driving vasomotor, cognitive, and metabolic symptoms, restoring the signaling environment that supports tissue protection across multiple organ systems.
Stabilize metabolic function
Estrogen loss impairs insulin sensitivity and shifts energy metabolism toward fat storage and inflammation. Targeting these metabolic pathways reduces cardiovascular risk accumulation and preserves mitochondrial efficiency during and after the transition.
Monitor hormonal biomarkers
Estradiol, progesterone, testosterone, FSH, and AMH levels shift dynamically throughout perimenopause. Precise, repeated measurement allows clinical protocols to track the transition in real time and adjust interventions as the hormonal landscape evolves.
Hear from our patients
Ahead of the field
Featured In
Featured In
“Rapamycin... is at the leading edge of a generation of research trials.”
“I would say that rapamycin is the current best-in-class for a longevity drug”
“Rapamycin... is at the leading edge of a generation of research trials.”
“I would say that rapamycin is the current best-in-class for a longevity drug”
“Rapamycin... is at the leading edge of a generation of research trials.”
“I would say that rapamycin is the current best-in-class for a longevity drug”
“Rapamycin... is at the leading edge of a generation of research trials.”
“I would say that rapamycin is the current best-in-class for a longevity drug”
Reviews
311 reviews